<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5599654</article-id><article-id pub-id-type="pmid">28912478</article-id><article-id pub-id-type="publisher-id">10286</article-id><article-id pub-id-type="doi">10.1038/s41598-017-10286-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The molecular epidemiology of HIV-1 in the Comunidad Valenciana (Spain): analysis of transmission clusters</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Pati&#x000f1;o-Galindo</surname><given-names>Juan &#x000c1;ngel</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Torres-Puente</surname><given-names>Manoli</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Bracho</surname><given-names>Mar&#x000ed;a Alma</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Alastru&#x000e9;</surname><given-names>Ignacio</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Juan</surname><given-names>Amparo</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Navarro</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Galindo</surname><given-names>Mar&#x000ed;a Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Ocete</surname><given-names>Dolores</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Ortega</surname><given-names>Enrique</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Gimeno</surname><given-names>Concepci&#x000f3;n</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Belda</surname><given-names>Josefina</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Dom&#x000ed;nguez</surname><given-names>Victoria</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Moreno</surname><given-names>Rosario</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0879-5798</contrib-id><name><surname>Gonz&#x000e1;lez-Candelas</surname><given-names>Fernando</given-names></name><address><email>fernando.gonzalez@uv.es</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Unidad Mixta Infecci&#x000f3;n y Salud P&#x000fa;blica FISABIO-CSISP/Universidad de Valencia-I2SysBio, Valencia, 46180 Spain </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9314 1427</institution-id><institution-id institution-id-type="GRID">grid.413448.e</institution-id><institution>CIBER of Epidemiology and Public Health, </institution><institution>Instituto de Salud Carlos III, </institution></institution-wrap>Madrid, 28029 Spain </aff><aff id="Aff3"><label>3</label>Unidad Prevenci&#x000f3;n del SIDA y otras ITS, Valencia, 46017 Spain </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.411308.f</institution-id><institution>Hospital Cl&#x000ed;nico Universitario, </institution></institution-wrap>Valencia, 46010 Spain </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2173 938X</institution-id><institution-id institution-id-type="GRID">grid.5338.d</institution-id><institution>Dpto. Microbiolog&#x000ed;a, </institution><institution>Universidad de Valencia, </institution></institution-wrap>46080 Valencia, Spain </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1770 977X</institution-id><institution-id institution-id-type="GRID">grid.106023.6</institution-id><institution>Consorcio Hospital General Universitario, </institution></institution-wrap>Valencia, 46014 Spain </aff><aff id="Aff7"><label>7</label>Unidad Prevenci&#x000f3;n del SIDA y otras ITS, Alicante, 03010 Spain </aff><aff id="Aff8"><label>8</label>Hospital General Universitario, Castello, 12004 Spain </aff></contrib-group><pub-date pub-type="epub"><day>14</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>14</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>11584</elocation-id><history><date date-type="received"><day>12</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>7</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">HIV infections are still a very serious concern for public heath worldwide. We have applied molecular evolution methods to study the HIV-1 epidemics in the Comunidad Valenciana (CV, Spain) from a public health surveillance perspective. For this, we analysed 1804 HIV-1 sequences comprising protease and reverse transcriptase (PR/RT) coding regions, sampled between 2004 and 2014. These sequences were subtyped and subjected to phylogenetic analyses in order to detect transmission clusters. In addition, univariate and multinomial comparisons were performed to detect epidemiological differences between HIV-1 subtypes, and risk groups. The HIV epidemic in the CV is dominated by subtype B infections among local men who have sex with men (MSM). 270 transmission clusters were identified (&#x0003e;57% of the dataset), 12 of which included &#x02265;10 patients; 11 of subtype B (9 affecting MSMs) and one (n&#x02009;=&#x02009;21) of CRF14, affecting predominately intravenous drug users (IDUs). Dated phylogenies revealed these large clusters to have originated from the mid-80s to the early 00&#x02009;s. Subtype B is more likely to form transmission clusters than non-B variants and MSMs to cluster than other risk groups. Multinomial analyses revealed an association between non-B variants, which are not established in the local population yet, and different foreign groups.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Of the four phylogenetic groups which comprise HIV-1 (M, N, O, P), group M is the causal agent of the AIDS pandemic<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. The latest UNAIDS/WHO report<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> estimated in almost 37 million the number of persons infected with HIV globally, with approximately 2.1 million new infections in 2015.</p><p id="Par3">Although the rate of new HIV diagnosis has stabilized from the early 2000s in the European Union and European Economic Area (EU/EEA), transmissions among men who have sex with men (MSM) have experienced a sustained increase, thus following a different trend to other risk groups<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. This is evident in Spain: during the late 90&#x02009;s, most HIV new diagnoses were associated to intravenous drug use (IDU). However, in 2013, 51% of the infections occurred among MSM<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. The increasing incidence among MSM is remarkably high in the age range 20&#x02013;35 years<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. HIV infections in Spain also affect the foreign population disproportionally: in 2012, 35% of the new diagnosis corresponded to immigrants or persons of foreign origin<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>.</p><p id="Par4">There exist nine subtypes (denoted as A, B, C, D, F, G, H, J and K) and at least 61 circulating recombinant forms (CRFs) within HIV-1 group M<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. There are differences among HIV-1 variants in several biological features. For instance, some subtypes and CRFs are associated to a faster progression to AIDS than others<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. Genetic and antigenic differences among HIV-1 subtypes and CRFs are also a challenge for the development of an effective HIV-1 vaccine<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>.</p><p id="Par5">Worldwide, the most prevalent HIV-1 subtype is C, accounting for around 50% of all cases. However, the HIV epidemic in Europe, particularly among MSM, is mainly driven by subtype B<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, with frequent reported transmission clusters affecting this group<sup><xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref></sup>. However, there is evidence for an increased introduction of non-B subtypes<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. For instance, in a sample of 206 patients from Spain, Abecasis and colleagues<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> found that CRF02_AG was the second most prevalent HIV-1 variant after subtype B (prevalence &#x0003c;2%).</p><p id="Par6">The Comunidad Valenciana (CV) is the fourth largest region in Spain (~5 million inhabitants), representing &#x0003e;10% of the total population. Genotypic tests of resistance to antiviral drugs are performed routinely for the design of individualized antiretroviral treatments. Here, we have analysed more than 1,800 HIV-1 <italic>pol</italic> sequences obtained between 2004 and 2014 from different patients in the CV. We have used molecular phylogenetic analyses to complement HIV surveillance tasks of the Public Health Directorate of the CV Regional Government. Specifically, we have used this information to infer the distribution of HIV-1 subtypes, to analyse the introductions (and further local expansion) of this virus in the CV, to identify the emergence of new viral variants in this region, and also to analyse which risk groups are currently more vulnerable to HIV infection. The results obtained from this work may be useful in establishing and reinforcing preventive measures in specific target groups.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><p id="Par7">Of the 1804 sequences analysed, 1512 (83.8%) belonged to subtype B. Among the 292 non-B sequences, the most prevalent HIV-1 variant was CRF02_AG (n&#x02009;=&#x02009;66, overall prevalence&#x02009;=&#x02009;3.7%), followed by subtypes A1, F1 (both n&#x02009;=&#x02009;34, 1.9%), CRF14_BG (n&#x02009;=&#x02009;28, 1.6%) and subtype G (n&#x02009;=&#x02009;20, 1.1%). Other variants (n&#x02009;=&#x02009;110) were present with a prevalence lower than 1.0%. Considering those patients for whom epidemiological information was available, 83.04% (930/1120) were male vs 16.96% (190/1120) female; 67.12% (637/949) were native from Spain (determined by place of birth) vs 32.87% (312/949) immigrants or of foreign origin; 66.84% (637/953) were MSM, 21.41% (204/953) heterosexual (HT) and 11.54% (110/953) IDUs. One patient was infected vertically and other one was haemophiliac. The mean age was 34.82 years (range 0 to 76) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). MSMs were more likely to be Spaniards than non-MSM (Fisher&#x02019;s Exact test, FET: p-value&#x02009;=&#x02009;5.5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>, odds-ratio, OR&#x02009;=&#x02009;1.84 (1.35&#x02013;2.48).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Distribution of HIV cases in the dataset (n&#x02009;=&#x02009;1804) classified by viral subtype, gender, nationality, risk group, age and clustering status.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td/><td>
<bold>B (n</bold>&#x02009;=&#x02009;<bold>1512)</bold>
</td><td>
<bold>A1 (n</bold>&#x02009;=&#x02009;<bold>34)</bold>
</td><td>
<bold>F1 (n</bold>&#x02009;=&#x02009;<bold>34)</bold>
</td><td>
<bold>G (n</bold>&#x02009;=&#x02009;<bold>20)</bold>
</td><td>
<bold>CRF02_AG (n</bold>&#x02009;=&#x02009;<bold>66)</bold>
</td><td>
<bold>CRF14_BG (n</bold>&#x02009;=&#x02009;<bold>28)</bold>
</td><td>
<bold>Others (n</bold>&#x02009;=&#x02009;<bold>110)*</bold>
</td><td>
<bold>Total (n</bold>&#x02009;=&#x02009;<bold>1804)</bold>
</td></tr><tr><td colspan="9">
<bold>Gender</bold>
</td></tr><tr><td>Male</td><td>818</td><td>10</td><td>13</td><td>5</td><td>24</td><td>11</td><td>49</td><td>930</td></tr><tr><td>Female</td><td>115</td><td>6</td><td>6</td><td>8</td><td>25</td><td>6</td><td>24</td><td>190</td></tr><tr><td>UNK</td><td>579</td><td>18</td><td>15</td><td>7</td><td>17</td><td>11</td><td>37</td><td>684</td></tr><tr><td colspan="9">
<bold>Geographical origin</bold>
</td></tr><tr><td>Spain</td><td>579</td><td>6</td><td>5</td><td>3</td><td>11</td><td>8</td><td>25</td><td>637</td></tr><tr><td>W. Europe and N. America</td><td>27</td><td>0</td><td>0</td><td>0</td><td>1</td><td>0</td><td>1</td><td>29</td></tr><tr><td>Eastern Europe</td><td>17</td><td>6</td><td>5</td><td>0</td><td>0</td><td>5</td><td>6</td><td>39</td></tr><tr><td>Africa and M. East</td><td>13</td><td>3</td><td>3</td><td>10</td><td>26</td><td>0</td><td>12</td><td>67</td></tr><tr><td>Latin America</td><td>141</td><td>1</td><td>3</td><td>0</td><td>7</td><td>3</td><td>19</td><td>174</td></tr><tr><td>Others</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td><td>3</td></tr><tr><td>UNK</td><td>734</td><td>18</td><td>18</td><td>7</td><td>21</td><td>12</td><td>45</td><td>855</td></tr><tr><td colspan="9">
<bold>Risk group</bold>
</td></tr><tr><td>HT</td><td>124</td><td>8</td><td>6</td><td>9</td><td>29</td><td>2</td><td>26</td><td>204</td></tr><tr><td>MSM</td><td>586</td><td>3</td><td>6</td><td>0</td><td>11</td><td>1</td><td>30</td><td>637</td></tr><tr><td>IDU</td><td>85</td><td>3</td><td>0</td><td>2</td><td>3</td><td>12</td><td>5</td><td>110</td></tr><tr><td>Other</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>2</td></tr><tr><td>UNK</td><td>715</td><td>20</td><td>22</td><td>9</td><td>23</td><td>13</td><td>49</td><td>851</td></tr><tr><td colspan="9">
<bold>Clustering</bold>
</td></tr><tr><td>No cluster</td><td>622</td><td>22</td><td>24</td><td>13</td><td>32</td><td>5</td><td>49</td><td>767</td></tr><tr><td>Small cluster (2&#x02013;3)</td><td>371</td><td>12</td><td>5</td><td>7</td><td>25</td><td>2</td><td>39</td><td>461</td></tr><tr><td>Medium cluster (4&#x02013;9)</td><td>240</td><td>0</td><td>5</td><td>0</td><td>9</td><td>0</td><td>22</td><td>276</td></tr><tr><td>Large cluster (&#x0003e;&#x02009;=&#x02009;&#x0003e;=10)</td><td>279</td><td>0</td><td>0</td><td>0</td><td>0</td><td>21</td><td>0</td><td>300</td></tr><tr><td>
<bold>Age: mean (min</bold>&#x02013;<bold>max)</bold>
</td><td>35.25 (14&#x02013;76)</td><td>32.8 (19&#x02013;56)</td><td>33.5 (18&#x02013;62)</td><td>28.9 (21&#x02013;41)</td><td>30.6 (19&#x02013;49)</td><td>38.11 (22&#x02013;65)</td><td>33.2 (0&#x02013;62)</td><td>34.82 (0&#x02013;76)</td></tr></tbody></table><table-wrap-foot><p>*The &#x0201c;Others&#x0201d; subset includes 10 subtype C, 1 subtype D, 13 CRF19_cpx, 12 CRF12_BF, 9 CRF06_cpx, 7 CRF47_BF and 58 other (mostly unassigned) recombinant sequences.</p></table-wrap-foot></table-wrap>
</p><p id="Par8">Phylogenetic analyses revealed the existence of 270 transmission clusters, with sizes ranging from 2 to 111 patients (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>). In total, 1039 patients from the dataset were included in a transmission cluster (57.5%), with 302 patients (16.7%) included in large clusters of 10 or more patients (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>). Among the 892 patients clustering in transmission groups of subtype B, 407 (45.6%) were MSM, 56 (6.3%) HTs, 38 (4.2%) IDUs and 391 (43.8%) of unknown transmission route. On the other hand, of the 147 patients clustering in non-B clusters 29 (19.7%) were HTs, 29 (19.7%) MSM, 15 (10.2%) IDUs and (50.3%) 74 of unknown transmission route (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1B</xref>). Among the transmission clusters that could be classified by the most frequent risk of transmission (&#x02265;50%) for the CV patients included in them, the most prevalent transmission clusters of subtype B were those classified as MSM (n&#x02009;=&#x02009;99/219, 45.2%), followed by IDUs (n&#x02009;=&#x02009;18/219, 8.2%) and HTs (n&#x02009;=&#x02009;15/219, 6.8%). However, for non-B transmission clusters, &#x0feff;thos&#x0feff;e of HTs were the most frequent ones (n&#x02009;=&#x02009;16/51, 31.4%), followed by MSM (n&#x02009;=&#x02009;14/51, 27.5%) and IDUs (n&#x02009;=&#x02009;1/51, 2.0%). 87 of the 219 (39.7%) subtype B clusters and 20 of 51 (39.2%) non-B clusters could not be classified based on a majority risk of transmission (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>). Subtype B sequences were more likely to be part of a transmission cluster than non-B sequences (FET: p-value&#x02009;=&#x02009;0.007, OR&#x02009;=&#x02009;1.42, 95% CI&#x02009;=&#x02009;1.09&#x02013;1.84). Also, MSM were more likely to be part of a transmission cluster than other risk groups (FET: p-value&#x02009;=&#x02009;1.68&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>, OR&#x02009;=&#x02009;1.56, 95% CI&#x02009;=&#x02009;1.23&#x02013;1.99).<fig id="Fig1"><label>Figure 1</label><caption><p>(<bold>A</bold>) Distribution of sizes (log10 scale) of the 270 transmission clusters found in the CV (2004&#x02013;2014) through phylogenetic analysis. Block letters indicate the 12 clusters that were analysed with BEAST. (<bold>B</bold>) Total number of patients for each risk group included in transmission clusters (n&#x02009;=&#x02009;1039). (<bold>C</bold>) Number of transmission clusters depending on the risk group in which they were classified. *&#x0003e;1/4 patients shared a known risk group, but they were not enough to classify the cluster.</p></caption><graphic xlink:href="41598_2017_10286_Fig1_HTML" id="d29e1160"/></fig>
</p><p id="Par9">Twelve large transmission clusters, which included at least 10 patients from the CV (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>), were detected: 11 were from subtype B and included a total of 281 patients (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref>). One cluster of 21 patients corresponded to CRF14_BG (Cluster K, Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2B</xref>). Patients infected with subtype B were more likely to form large transmission clusters than those infected with non-B variants (FET: p-value&#x02009;=&#x02009;3.4&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup>, OR&#x02009;=&#x02009;2.94, 95% CI&#x02009;=&#x02009;1.84&#x02013;4.92). Nine of the large clusters were classified as MSM; the other three included mostly IDUs, although in a proportion lower than 50% (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Dated phylogenies of these clusters (Supplementary Figs&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref> to <xref rid="MOESM1" ref-type="media">12</xref>) revealed that they originated between 1984 (cluster G, unclassified transmission route) and 2005 (cluster B, MSM). Only transmission clusters that included MSM as the main transmission risk were originated since 2000 (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>; Supplementary Figs&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref> to <xref rid="MOESM1" ref-type="media">12</xref>). Bagplots (bivariate representations of boxplots<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>) representing tree height (the time elapsed between tMRCA and the sampling date of the last sequence) and evolutionary rate estimates from the posterior distribution of each large cluster are shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. A significant, negative correlation between median tree height and substitution rate estimates of these large clusters was obtained (R&#x02009;=&#x02009;&#x02212;0.70, p-value&#x02009;=&#x02009;0.013).<fig id="Fig2"><label>Figure 2</label><caption><p>Maximum likelihood trees with the 12 largest transmission clusters highlighted in red. (<bold>A</bold>) Subtype B tree (clusters A-J, L). (<bold>B</bold>) Subtype G and CRF14_BG tree (cluster K).</p></caption><graphic xlink:href="41598_2017_10286_Fig2_HTML" id="d29e1217"/></fig>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Size (n, number of patients), risk group, range of sampling dates and root-to-tip vs sampling date correlation coefficient for each transmission cluster (R), and estimates of their tMRCAs (median) and substitution rates as obtained with BEAST under the best-fitting demographic model (EXPO: exponential growth; BSP: Bayesian Skyline Plot; LOG: logarithmic growth).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Transmission cluster</th><th>n</th><th>risk group</th><th>range #</th><th>R</th><th>Model</th><th>tMRCA (95% HPD)#</th><th>Substitution rate (95% HPD)*</th></tr></thead><tbody><tr><td>A</td><td>10</td><td>MSM</td><td>2004&#x02013;2011</td><td>(&#x02212;0.08)</td><td>EXPO</td><td>1984.7 (1971.2&#x02013;1994.5)</td><td>0.0014 (0.0009&#x02013;0.0021)</td></tr><tr><td>B</td><td>13</td><td>MSM</td><td>2007&#x02013;2013</td><td>0.61</td><td>BSP</td><td>2005.9 (2003.8&#x02013;2006.9)</td><td>0.0043 (0.0016&#x02013;0.0087)</td></tr><tr><td>C</td><td>15</td><td>UNK/IDU</td><td>2004&#x02013;2014</td><td>(&#x02212;0.18)</td><td>BSP</td><td>1988.0 (1969.0&#x02013;1999.2)</td><td>0.0015 (0.0007&#x02013;0.0025)</td></tr><tr><td>D</td><td>16</td><td>MSM</td><td>2011- 2013</td><td>(&#x02212;0.05)</td><td>LOG</td><td>1994.9 (1982.4&#x02013;2006.3)</td><td>0.0022 (0.0012&#x02013;0.0034)</td></tr><tr><td>E</td><td>18</td><td>UNK/MSM</td><td>2010&#x02013;2014</td><td>0.25</td><td>EXPO</td><td>2002.2 (1995.9&#x02013;2006.8)</td><td>0.0018 (0.0011&#x02013;0.0027)</td></tr><tr><td>F</td><td>18</td><td>MSM</td><td>2008&#x02013;2013</td><td>0.40</td><td>LOG</td><td>1999.3 (1989.6&#x02013;2005.0)</td><td>0.0013 (0.0005&#x02013;0.0023)</td></tr><tr><td>G</td><td>19</td><td>UNK</td><td>2004&#x02013;2013</td><td>(&#x02212;0.05)</td><td>EXPO</td><td>1984.3 (1966.9&#x02013;1997.0)</td><td>0.0011 (0.0006&#x02013;0.0019)</td></tr><tr><td>H</td><td>19</td><td>MSM</td><td>2008&#x02013;2014</td><td>0.58</td><td>BSP</td><td>2002.1 (1995.9&#x02013;2006.2)</td><td>0.0019 (0.0010. 0.0029)</td></tr><tr><td>I</td><td>21</td><td>MSM</td><td>2004&#x02013;2012</td><td>0.58</td><td>LOG</td><td>1994.6 (1982.2&#x02013;2001.3)</td><td>0.0012 (0.0005&#x02013;0.0020)</td></tr><tr><td>J</td><td>21</td><td>MSM</td><td>2004&#x02013;2013</td><td>0.76</td><td>LOG</td><td>1999.5 (1993.2&#x02013;2003.4)</td><td>0.0023 (0.0010&#x02013;0.0045)</td></tr><tr><td>K</td><td>21</td><td>UNK/IDU</td><td>2004&#x02013;2014</td><td>0.62</td><td>BSP</td><td>1990.6 (1979.6&#x02013;1998.1)</td><td>0.0010 (0.0005&#x02013;0.0016)</td></tr><tr><td>L</td><td>111</td><td>MSM</td><td>2006&#x02013;2014</td><td>0.61</td><td>EXPO</td><td>2001.8 (1998.6&#x02013;2004.8)</td><td>0.0028 (0.0022&#x02013;0.0035)</td></tr></tbody></table><table-wrap-foot><p>
<sup>#</sup>Time measured in years. *Substitutions per site and year.</p></table-wrap-foot></table-wrap>
<fig id="Fig3"><label>Figure 3</label><caption><p>Bagplots representing tree height and evolutionary rate estimates, obtained from the posterior distribution of the 12 largest transmission clusters detected (<bold>A</bold> to <bold>L</bold>).</p></caption><graphic xlink:href="41598_2017_10286_Fig3_HTML" id="d29e1584"/></fig>
</p><p id="Par10">Despite most patients infected with subtype B were Spanish natives (579 Spaniards vs 199 foreigners), a majority of those infected with non-B variants were foreigners (58 vs 113; FET: p-value&#x02009;&#x0003c;&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>, OR&#x02009;=&#x02009;5.66, 95% CI&#x02009;=&#x02009;3.91&#x02013;8.23). This difference was also observed when considering only patients belonging to a transmission cluster (subtype B: 378 vs 114; non-B: 31 vs 47; FET: p-value&#x02009;=&#x02009;1.8&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;10</sup>; OR&#x02009;=&#x02009;5.01, 95% CI&#x02009;=&#x02009;2.96&#x02013;8.57) (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>).</p><p id="Par11">A total of 88 subtype B, and 9 non-B transmission clusters did not include patients of foreign origin. These subtype B clusters included 178 Spanish patients and 122 of unknown origin, and the non-B clusters included 13 Spanish patients and 14 of unknown origin. A total of 49 subtype B, and 7 non-B transmission clusters were formed by both Spanish and non-Spanish patients. Altogether, these mixed subtype B clusters included 200 Spanish, 87 non-Spanish (mostly from Latin America) and 113 of unknown origin, and the mixed non-B clusters included 18 Spanish, 10 non-Spanish (mostly from Latin America or Eastern Europe) and 13 of unknown origin. All large transmission clusters but one (cluster G, for which there was not information available in 17 of its 19 patients) presented this characteristic. Finally, a total of 16 subtype B and 25 non-B transmission clusters included only patients of foreign origin. These subtype B clusters included 27 foreign patients (mostly from Latin America) and 16 of unknown origin, and the non-B clusters included 37 foreign patients (mostly from Africa/Middle East and Latin America) and 20 of unknown origin (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>).</p><p id="Par12">In addition to the patients&#x02019; origin, other variables considered for the multinomial analysis presented differences between subtypes. So, subtype B sequences were disproportionally more present in males compared to females (FET: p-value&#x02009;&#x0003c;&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>, OR&#x02009;=&#x02009;4.75, 95% CI&#x02009;=&#x02009;3.29&#x02013;6.86), in MSM with respect to HTs and IDUs (p-value&#x02009;&#x0003c;&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16</sup>, OR&#x02009;=&#x02009;7.4, 95% CI&#x02009;=&#x02009;4.87&#x02013;11.31 and p-value&#x02009;=&#x02009;2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>, OR&#x02009;=&#x02009;3.37, 95% CI&#x02009;=&#x02009;1.90&#x02013;5.89, respectively), and in IDUs compared to HTs (p-value&#x02009;=&#x02009;0.0038, OR&#x02009;=&#x02009;2.19, 95% CI&#x02009;=&#x02009;1.26&#x02013;3.88). There were also differences between subtypes with respect to age distribution (Kruskal-Wallis test: P&#x02009;=&#x02009;0.0013, Chi<sup>2</sup>&#x02009;=&#x02009;21.8, df&#x02009;=&#x02009;6), with CRF02_AG patients being significantly younger than B patients (Games-Howell post-hoc test result for this comparison: p&#x02009;=&#x02009;0.001, t&#x02009;=&#x02009;4.37, df&#x02009;=&#x02009;58). Given that no significant differences were found between subtypes in the distribution of collection dates (P&#x02009;&#x0003e;&#x02009;0.70), this variable was excluded from the multinomial analysis.</p><p id="Par13">Multinomial analyses were performed using a subset of 906 patients for whom there was information for all the variables considered: sex, risk group, country of origin, clustering status and age. We considered as baseline the most frequent category for each variable (subtype B, Spaniard, male, MSM, age between 21 and 29 years and not clustering), and a significant model was obtained (McFadden R<sup>2</sup>&#x02009;=&#x02009;0.32, Chi<sup>2</sup>&#x02009;=&#x02009;421.34, p-value&#x02009;&#x0003c;&#x02009;2.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;16)</sup>). We checked that this subset was representative of the global set (n&#x02009;=&#x02009;1804) by means of FETs. The p-values obtained for all the analysed variants were &#x0003e;0.05, including the distribution of patients from the different cluster-size categories (no cluster, small cluster, medium cluster and large cluster) that would result if only sequences included in the multinomial analysis had been taken into account for cluster detection, (FET: P&#x02009;&#x0003e;&#x02009;0.10; Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). This dataset was also genetically representative of the whole dataset (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S13</xref>). The multivariate model shows that the chances of being infected with all non-B groups increased in foreign patients, coming from Eastern Europe (A1, F1, 14_BG and the pooled, rare, variants), Africa and the Middle East (F1, G, 02_AG and the rare variants) and Latin America (rare variants), with all p-values&#x02009;&#x0003c;&#x02009;0.01, all ORs &#x0003e;3.0. The likelihood of being infected with CRF14_BG also increased in patients older than 50 years (p-value&#x02009;=&#x02009;0.029, OR&#x02009;=&#x02009;36.2, 95% CI&#x02009;=&#x02009;1.45&#x02013;904.0), in IDUs (p-value&#x02009;=&#x02009;9.44&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>, OR&#x02009;=&#x02009;257, 95% CI&#x02009;=&#x02009;15.8&#x02013;4160) and in those patients forming large transmission clusters (p-value&#x02009;=&#x02009;1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>, OR&#x02009;=&#x02009;36.9, 95% CI&#x02009;=&#x02009;5.67&#x02013;240) (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Results of the multinomial analysis (only significant associations between each HIV variant and the categories compared at each variable are shown).</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="9">Coefficients</th></tr><tr><th/><th>Estimate</th><th>Std error</th><th>t-value</th><th>Pr(&#x0003e;|t|)</th><th/><th>OR</th><th>2.50%</th><th>97.50%</th></tr></thead><tbody><tr><td>14_BG:Age(&#x0003e;50)</td><td>3.59</td><td>1.64</td><td>2.188</td><td>0.028696</td><td>*</td><td>36.2</td><td>1.45</td><td>904</td></tr><tr><td>14_BG:RISK(HT)</td><td>2.39</td><td>1.43</td><td>1.674</td><td>0.094265</td><td>$</td><td>11.0</td><td>0.664</td><td>181</td></tr><tr><td>02_AG:RISK(HT)</td><td>1.07</td><td>0.579</td><td>1.850</td><td>0.064773</td><td>$</td><td>2.91</td><td>0.937</td><td>9.07</td></tr><tr><td>14_BG:RISK(UDI)</td><td>5.55</td><td>1.42</td><td>3.905</td><td>9.44E-05</td><td>***</td><td>257.0</td><td>15.8</td><td>4160</td></tr><tr><td>14_BG:Eastern Europe</td><td>3.29</td><td>1.09</td><td>3.023</td><td>0.002502</td><td>**</td><td>26.9</td><td>3.18</td><td>227</td></tr><tr><td>F:Eastern Europe</td><td>3.51</td><td>1.08</td><td>3.250</td><td>0.001155</td><td>**</td><td>33.5</td><td>4.03</td><td>279</td></tr><tr><td>OTHERS: Eastern Europe</td><td>2.01</td><td>0.583</td><td>3.448</td><td>0.000566</td><td>***</td><td>7.47</td><td>2.38</td><td>23.5</td></tr><tr><td>A1:Eastern Europe</td><td>2.78</td><td>0.795</td><td>3.493</td><td>0.000478</td><td>***</td><td>16.1</td><td>3.38</td><td>76.3</td></tr><tr><td>F1:Africa and Middle East</td><td>3.50</td><td>1.05</td><td>3.353</td><td>0.000799</td><td>***</td><td>33.3</td><td>4.29</td><td>258</td></tr><tr><td>G:Africa and Middle East</td><td>3.78</td><td>1.17</td><td>3.236</td><td>0.001218</td><td>**</td><td>43.7</td><td>4.43</td><td>431</td></tr><tr><td>OTHERS: Africa and Middle East</td><td>2.77</td><td>0.554</td><td>5.009</td><td>5.48E-07</td><td>***</td><td>16.0</td><td>5.41</td><td>47.4</td></tr><tr><td>A1:Africa and Middle East</td><td>1.92</td><td>0.993</td><td>1.932</td><td>0.053351</td><td>$</td><td>6.81</td><td>0.973</td><td>47.7</td></tr><tr><td>02_AG:Africa and Middle East</td><td>3.76</td><td>0.580</td><td>6.478</td><td>9.28E-11</td><td>***</td><td>42.9</td><td>13.8</td><td>134</td></tr><tr><td>14_BG:Latin America</td><td>2.71</td><td>1.38</td><td>1.955</td><td>0.050547</td><td>$</td><td>15.0</td><td>0.994</td><td>225</td></tr><tr><td>OTHERS:Latin America</td><td>1.19</td><td>0.352</td><td>3.391</td><td>0.000696</td><td>**</td><td>3.30</td><td>1.66</td><td>6.58</td></tr><tr><td>14_BG:ClusterLARGE</td><td>3.61</td><td>0.955</td><td>3.776</td><td>0.000159</td><td>***</td><td>36.9</td><td>5.67</td><td>240</td></tr></tbody></table><table-wrap-foot><p>***P&#x02009;&#x0003c;&#x02009;0.001; **0001&#x02009;&#x0003c;&#x02009;P&#x02009;&#x0003c;&#x02009;0.01; *0.01&#x02009;&#x0003c;&#x02009;P&#x02009;&#x0003c;&#x02009;0.05; $0.05&#x02009;&#x0003c;&#x02009;P&#x02009;&#x0003c;&#x02009;0.</p></table-wrap-foot></table-wrap>
</p><p id="Par14">Pairwise genetic distances (GD) between individuals from a given transmission cluster ranged between 0.00 substitutions/site (s/s), in clusters of sizes of 2, 3, 5, 7, 8, 15, 16, 18 and 111 individuals, and 0.073&#x02009;s/s, in a cluster of 6 individuals. For most pairwise comparisons, GD was lower than 0.045&#x02009;s/s, regardless the size of the transmission cluster (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>; Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>Boxplots representing mean pairwise genetic distances (s/s) between individuals within transmission clusters of different sizes, as estimated with the TN93&#x02009;+&#x02009;GAMMA (4 CAT) model. Green and red bars represent the minimum and maximum pairwise distances, respectively, between a pair of individuals from a given cluster size.</p></caption><graphic xlink:href="41598_2017_10286_Fig4_HTML" id="d29e2159"/></fig>
</p></sec><sec id="Sec3" sec-type="discussion"><title>Discussion</title><p id="Par15">We have studied the HIV epidemic in the Comunidad Valenciana by analysing, with molecular and evolutionary tools, 1804 sequences obtained between 2004 and 2014 from different patients. Our results indicate that the HIV epidemic in the CV is dominated by HIV-1 subtype B infections among local MSM. However, non-B infections represented an important number of cases, with a prevalence higher than 15%, being CRF02_AG the most prevalent non-B variant (prevalence&#x02009;=&#x02009;3.7%), in agreement with previous estimates for Spain<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>.</p><p id="Par16">Overall, the detection of transmission clusters demonstrates the importance of the domestic spread of HIV-1 in the CV. Most patients from the whole dataset (&#x0003e;57%) were included in local transmission clusters, of sizes ranging from 2 to 111 individuals. Local transmission was especially important among MSM, who were more likely to be included in a transmission cluster, as well as for Spanish natives, than other risk groups. Considering the 12 largest clusters (size &#x02265;10 patients), this transmission risk was the most frequent in 9 of them. Excluding transmission cluster A (MSM, tMRCA&#x02009;=&#x02009;1984.7), MSM clusters were of more recent origin as estimated using Bayesian coalescent analyses, especially clusters B (n&#x02009;=&#x02009;13), E (n&#x02009;=&#x02009;18), H (n&#x02009;=&#x02009;19) and L (n&#x02009;=&#x02009;111), which originated after year 2000. Previous analyses in the Spanish regions of Madrid<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and the Basque Country<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> detected lower proportions of clustering patients (18 and 27% of their analysed sequences, respectively). These results suggest that the importance of local transmissions may not be the same in different Spanish regions. In addition, they also found evidences for an increased vulnerability to HIV of the Spanish MSM community in recent years. A more detailed analysis of cluster L is provided elsewhere<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p><p id="Par17">Immigrants were disproportionally represented in the dataset (almost 1/3 of the patients were of non-Spanish origin), reflecting their higher vulnerability to HIV infection. Multinomial analyses evidenced the significant association between all non-B groups analysed and different foreign populations: Eastern Europe (subtypes A1, F1, CRf14_BG and the rare variants), Africa and the Middle East (subtypes F1, G, CRF02_AG and rare variants) and Latin America (rare variants). These associations were in agreement with the geographical distributions of these variants<sup><xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref></sup>. These results, along with the fact that most non-B patients, either clustering or not, were of non-Spanish origin (CRF14_BG was the only exception) suggest that along the analysed time-span non-B HIV variants were not well established among Spanish locals in this region. This is exemplified by the fact that almost half of the non-B transmission clusters did not include any Spanish patient. Furthermore, non-B patients clustered in a significantly lower proportion than patients infected with subtype B, especially when considering clusters with at least 10 patients, thus displaying significantly lower local transmission efficiency. Previous molecular epidemiology studies of HIV-1 in Western Europe also reported non-B variants to be associated with the migrant population<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, mainly affecting HTs. In the Spanish region of Madrid, where non-B variants have been found with a prevalence of up to 37%<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, more than 70% of non-B sequences were found to belong to non-Spanish patients<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Other works in different Western European countries have reported differences in the prevalence of non-B variants in the migrant population. Similarly to our results, in countries such as Switzerland (estimated prevalence of non-B HIV sequences&#x02009;=&#x02009;21%<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>) or the Belgian-Luxemburg population (prevalence &#x0003e;45%<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>) nearly 70% of non-B variants have been associated to patients of migrant origin<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. These results contrast with those from Portugal, the Western European country where subtype B displays the lowest prevalence<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. An study in the Portuguese region of Minho (close to the border with Spain) found non-B variants to have a prevalence of 73%, and only 10% of these sequences belonged to non-Portuguese patients<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>, thus evidencing that non-B infections are already established among locals.</p><p id="Par18">Although 11 of the 12 largest transmission clusters were of subtype B, one of the largest clusters found (n&#x02009;=&#x02009;21, median tMRCA&#x02009;=&#x02009;1990.6) corresponded to the CRF14_BG, and included a high number of IDUs from Spain. CRF14 has been associated to a predominance of CXCR4 tropism, which usually leads to faster AIDS onset<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>. Previous phylogeographic analyses have suggested that CRF14_BG originated in the Iberian Peninsula<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, and its prevalence is increasing in some Eastern European countries, such as Romania, boosted by migration between these countries and Spain<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Similarly to Romania, this CRF has been found to be common among IDUs in Greece, where a large transmission network of CRF14_BG of recent origin (tMRCA&#x02009;=&#x02009;2009) has been reported to affect more than 70 people, and which origin has been linked to strains from South-western Europe<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p><p id="Par19">We also detected two other transmission clusters of smaller size (n&#x02009;=&#x02009;5 and n&#x02009;=&#x02009;4) affecting Spanish-native MSMs of another highly pathogenic variant (CRF19_cpx), which we previously reported as the first evidence of expansion of this variant outside Cuba<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Despite the prevalence of these CRFs remaining low in the CV, the effective expansion of these highly pathogenic HIV variants, evidenced by the detection of transmission clusters, is of especial interest because it may hamper the control of the local HIV epidemic, especially among vulnerable populations such as IDUs or MSMs.</p><p id="Par20">The significant association between non-B variants and immigrants reported in this work and in previous molecular epidemiology analyses of HIV-1 in Madrid, Spain<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>, as well as the aforementioned examples of emergence of CRFs associated with migratory waves, suggest that high migration and tourism rates in some Spanish regions may contribute to the high genetic diversity of their HIV-1 epidemics. Thus, although our results suggest that non-B HIV groups are not well established in the local population, with only a few of them including patients of both Spanish and non-Spanish origin, this situation could change soon without intensified HIV prevention campaigns focused on vulnerable groups, including migrants, IDUs and MSM.</p><p id="Par21">Although the large number of sequences for which no epidemiological information was available could be a potential limitation of our study, the results reported are representative of the sampled population and represent one of the most comprehensive analysis of the HIV pandemics in Spain<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>.</p><p id="Par22">We have found a significant, negative correlation between tree height and evolutionary rate estimates obtained when comparing the 12 largest clusters. Several publications have addressed this time-dependency on the evolutionary rate (TDRP), that is, virus lineages estimated to have a recent origin yield higher estimated evolutionary rates than older viruses<sup><xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref></sup>. In our study the most plausible explanation for this phenomenon is the overestimation of evolutionary rates in the most recent clusters, caused by the presence of deleterious mutations over which purifying selection has not had time to act. This phenomenon might be potentiated by the bottlenecks that occur at viral transmission, which might originate a transient accumulation of deleterious mutations. Consequently, these results suggest that TDRP is an important factor to consider in molecular epidemiology, even when datasets are obtained from the same population and at short timescales (in this case 10 years, from 2004 to 2014).</p><p id="Par23">It is also important to mention that many works on the molecular epidemiology of HIV-1 remove resistance-associated positions from the analysis, in order to prevent spurious clustering by convergent evolution. In our analyses, we did not remove those positions because their impact on the detection of transmission clusters has been demonstrated to be irrelevant<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Furthermore, a great majority of our sequences were known to derive from treatment-na&#x000ef;ve patients (only 66 patients were known to have been treated).</p><p id="Par24">Additionally, although the identification or detection of transmission clusters is commonly based only on phylogenetic cluster support, it is also often based on criteria that combine phylogenetic support, usually high bootstrap values, with genetic distance (GD) thresholds<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. In this work, we did not consider any GD threshold value as criterion to define transmission clusters. This is because the rationale for genetic distance cut-offs is rarely provided, with very different thresholds being reported in the literature<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, and larger GD values are expected for older transmission events. In this way, choosing distance-based thresholds can lead to underestimating transmission clusters, especially those that span long time periods<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>, as it is the case of our dataset. Nevertheless, a great majority of GDs estimated from the pairwise comparisons performed here were lower than 0.045&#x02009;s/s. Thus, almost all the transmission clusters reported here would be characterized by both high phylogenetic support and low GD.</p><p id="Par25">In conclusion, our results provide evidence that the HIV-1 epidemic in the CV is dominated by subtype B, especially among local MSMs. Although there was an important number of non-B cases, they occurred mostly among immigrants. This suggests that non-B infections are not well established in the local population. However, the detection of transmission clusters of non-B variants associated to a higher pathogenicity and affecting Spanish patients, urges to increase efforts on HIV testing and prevention campaigns to prevent their further expansion.</p></sec><sec id="Sec4" sec-type="materials|methods"><title>Materials and Methods</title><sec id="Sec5"><title>Dataset</title><p id="Par26">A total of 1804 PR/RT sequences were obtained from newly HIV diagnosed people at six different hospitals and two HIV counselling and testing centres (CIPS) from the three provinces in the CV between 2004 and 2014. The sequences comprised the complete PR and the first 1005 nucleotides (335 amino acids) of the RT (1302 nt in total), and were obtained and subtyped as detailed in Pati&#x000f1;o-Galindo <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>.</p></sec><sec id="Sec6"><title>Detection of local transmission clusters</title><p id="Par27">Detection of transmission clusters, was performed following the same two-step procedure detailed in Pati&#x000f1;o-Galindo <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Briefly, in the first step, we obtained independent phylogenetic trees for each HIV-1 subtype and CRF detected, which included reference sequences retrieved from the Los Alamos HIV database spanning the analysed PR/RT region (n&#x02009;=&#x02009;1787 subtype B, 2097 A1, 720 F1, 854&#x02009;G&#x02009;+&#x02009;CRF14_BG and 2157 CRF02_AG, as well as 5720 sequences from all the HIV-1 subtypes/CRFs that were rare in the CV dataset). The initial trees were reconstructed with FastTree 2.1 in order to detect potential transmission clusters, defined as clades with SH-like support &#x02265;0.70, and containing &#x02265;90% sequences from the CV dataset<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>.</p><p id="Par28">In the second step, these potential clusters were confirmed with ML phylogenies obtained with PhyML 3.0<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> in which the following additional reference sequences were included: (i) the 10 sequences with the highest similarity to each CV sequence from the potential clusters, as retrieved with a BLASTN search at the NCBI server (<ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>); (ii) 854 subtype B, 77 A1, 74 F1, 173&#x02009;G&#x02009;+&#x02009;CRF14_BG, 101 CRF02_AG as well as 482 reference sequences from the other HIV-1 subtypes/CRFs. Only those potential clusters which contained more than 90% of sequences from the CV and grouped in the ML tree with aLRT support &#x02265;0.98 were considered as confirmed. Clusters were then classified depending on the major risk of transmission (&#x02265;50%) for the corresponding patients from the CV.</p></sec><sec id="Sec7"><title>Dated phylogenies</title><p id="Par29">Dated phylogenies of large transmission clusters (those containing at least 10 patients from the CV<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>) were obtained with BEAST v1.8.1<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>, similarly as in Pati&#x000f1;o-Galindo <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. In those clusters with low root-to-tip divergence vs sampling date correlation (R&#x02009;&#x0003c;&#x02009;0.4), a log-normal prior (median&#x02009;=&#x02009;0.0025 per site and year, s/s/y, 95% HPD upper limit&#x02009;=&#x02009;0.0035&#x02009;s/s/y)<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> was placed on the ucld.mean parameter.</p></sec><sec id="Sec8"><title>Statistical analyses</title><p id="Par30">A multinomial logistic regression analysis was performed in order to identify the main predictors of HIV-1 subtype/CRF group distribution, considering relevant epidemiologic variables: country of origin, sex, risk group, collection date, age and clustering status. Due to the lack of epidemiological data for many sequences from the dataset, only 906 of the 1804 sequences were included in this analysis. Seven groups of different HIV-1 subtypes and CRFs were used: A1 (n&#x02009;=&#x02009;14), B (n&#x02009;=&#x02009;752), F1 (n&#x02009;=&#x02009;13), G (n&#x02009;=&#x02009;11), 02_AG (n&#x02009;=&#x02009;42) and 14_BG (n&#x02009;=&#x02009;15). All HIV-1 variants with fewer than 10 patients sampled were pooled as &#x0201c;Other variants&#x0201d; (n&#x02009;=&#x02009;59). Prior to the multinomial analysis, univariate analyses (Fisher&#x02019;s Exact Tests) were performed for the aforementioned variables, in order to exclude from the multinomial analysis those with non-significant p-values. Only the variable &#x0201c;collection date&#x0201d; (p-value&#x02009;&#x0003e;&#x02009;0.70) was excluded. In the multinomial analysis, the most representative category of each variable was used as &#x0201c;baseline category&#x0201d; (Subtype B, Spaniard, male, MSM, age between 21 and 29 years and not clustering; Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>). All the statistical analyses were performed using R<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. The mlogit R package<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> was used for the multinomial analysis.</p></sec><sec id="Sec9"><title>Estimation of pairwise genetic distances</title><p id="Par31">Pairwise genetic distances (GD) between individuals within transmission clusters were estimated, as substitutions per site (s/s), with the TN93&#x02009;+&#x02009;&#x00393;(4CAT) model, using Perl and R scripts (available upon request) dependent on the ape R package<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>.</p></sec><sec id="Sec10"><title>Sequence information</title><p id="Par32">GenBank accession numbers for the CV sequences used in this study are HF567872-HF567912 and MF403205&#x02013;MF404967.</p></sec></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec11"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2017_10286_MOESM1_ESM.pdf"><caption><p>Supplementary Material</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>
<bold>Supplementary information</bold> accompanies this paper at doi:10.1038/s41598-017-10286-1
</p></fn><fn><p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>This work was partly supported by project BFU2014-58656-R from Ministerio de Econom&#x000ed;a y Competitividad (Spanish Government) and project PROMETEO/2016/122 from Generalitat Valenciana to F.G.C., project CP07/00078 from Ministerio de Sanidad y Consumo (Spanish Government) to M.A.B., and Gilead Science S.L. J.A.P.G. was recipient of a fellowship (FPU-AP2010-0561) from Ministerio de Educaci&#x000f3;n&#x0feff;,&#x0feff; Cultura y Deporte, Spanish Government. The funders played no role on the design, analysis and conclusions from this work. We thank the CRIVIH for their support of this investigation.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>J.A.P.G., M.T.P., M.A.B. and F.G.C. designed the study. M.T.P. and M.A.B. performed the experiments. J.A.P.G. and F.G.C. analysed the data. M.T.P., M.A.B., I.A., A.J., D.N., M.J.G., D.O., E.O., C.G., J.B., V.D., R.M. contributed data. J.A.P.G. and F.G.C. wrote the paper. All authors reviewed the manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p id="Par33">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>BH</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>De Cock</surname><given-names>KM</given-names></name><name><surname>Sharp</surname><given-names>PM</given-names></name></person-group><article-title>AIDS as a zoonosis: scientific and public health implications</article-title><source>Science</source><year>2000</year><volume>287</volume><fpage>607</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1126/science.287.5453.607</pub-id><?supplied-pmid 10649986?><pub-id pub-id-type="pmid">10649986</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plantier</surname><given-names>J-C</given-names></name><etal/></person-group><article-title>A new human immunodeficiency virus derived from gorillas</article-title><source>Nat. Med.</source><year>2009</year><volume>15</volume><fpage>871</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1038/nm.2016</pub-id><?supplied-pmid 19648927?><pub-id pub-id-type="pmid">19648927</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">UNAIDS. Fact sheet &#x02013; Latest global and regional statistics on the status of the AIDS epidemic. (2016).</mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">ECDC. Thematic report: Men who have sex with men. Monitoring implementation of the Dublin Declaration on Partnership to fight HIV/AIDS in Europe and Central Asia: 2012 progress report. (2013).</mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">UNAIDS (Joint United Nations Programme on HIV/AIDS). Report on the global HIV/AIDS epidemic. 1&#x02013;226 (2002).</mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="other">DGSP. Vigilancia epidemiol&#x000f3;gica del VIH/SIDA enEspa&#x000f1;a: Sistema de informaci&#x000f3;n sobre nuevos diagn&#x000f3;sticos del VIH y registro nacional de casos de SIDA. (2014).</mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Kuiken, C. L. <italic>et al</italic>. <italic>HIV Sequence Compendium 2012</italic> (2012).</mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaleebu</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda</article-title><source>J. Infect. Dis.</source><year>2002</year><volume>185</volume><fpage>1244</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1086/340130</pub-id><?supplied-pmid 12001041?><pub-id pub-id-type="pmid">12001041</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouri</surname><given-names>V</given-names></name><etal/></person-group><article-title>CRF19_cpx is an Evolutionary fit HIV-1 Variant Strongly Associated With Rapid Progression to AIDS in Cuba</article-title><source>EBioMedicine</source><year>2015</year><volume>2</volume><fpage>244</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2015.01.015</pub-id><?supplied-pmid 26137563?><pub-id pub-id-type="pmid">26137563</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickle</surname><given-names>DC</given-names></name><etal/></person-group><article-title>Coping with viral diversity in HIV vaccine design</article-title><source>PLoS Comput. Biol.</source><year>2007</year><volume>3</volume><fpage>e75</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.0030075</pub-id><?supplied-pmid 17465674?><pub-id pub-id-type="pmid">17465674</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abecasis</surname><given-names>AB</given-names></name><etal/></person-group><article-title>HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics</article-title><source>Retrovirology</source><year>2013</year><volume>10</volume><fpage>7</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-10-7</pub-id><?supplied-pmid 23317093?><pub-id pub-id-type="pmid">23317093</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouyos</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland</article-title><source>J. Infect. Dis.</source><year>2010</year><volume>201</volume><fpage>1488</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1086/651951</pub-id><?supplied-pmid 20384495?><pub-id pub-id-type="pmid">20384495</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>F</given-names></name><name><surname>Hughes</surname><given-names>GJ</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name><name><surname>Pozniak</surname><given-names>A</given-names></name><name><surname>Leigh Brown</surname><given-names>AJ</given-names></name></person-group><article-title>Episodic sexual transmission of HIV revealed by molecular phylodynamics</article-title><source>PLoS Med.</source><year>2008</year><volume>5</volume><fpage>e50</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.0050050</pub-id><?supplied-pmid 18351795?><pub-id pub-id-type="pmid">18351795</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leigh Brown</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Transmission network parameters estimated from HIV sequences for a nationwide epidemic</article-title><source>J. Infect. Dis.</source><year>2011</year><volume>204</volume><fpage>1463</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir550</pub-id><?supplied-pmid 21921202?><pub-id pub-id-type="pmid">21921202</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuevas</surname><given-names>MT</given-names></name><etal/></person-group><article-title>HIV-1 transmission cluster with T215D revertant mutation among newly diagnosed patients from the Basque Country, Spain</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2009</year><volume>51</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e318199063e</pub-id><?supplied-pmid 19282784?><pub-id pub-id-type="pmid">19282784</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zehender</surname><given-names>G</given-names></name><etal/></person-group><article-title>Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy</article-title><source>J. Acquir. Immune Defic. Syndr.</source><year>2010</year><volume>55</volume><fpage>156</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1097/QAI.0b013e3181eb3002</pub-id><?supplied-pmid 20703157?><pub-id pub-id-type="pmid">20703157</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu&#x000e9;</surname><given-names>S</given-names></name><name><surname>Pillay</surname><given-names>D</given-names></name><name><surname>Clewley</surname><given-names>JP</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name></person-group><article-title>Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2005</year><volume>102</volume><fpage>4425</fpage><lpage>4429</lpage><pub-id pub-id-type="doi">10.1073/pnas.0407534102</pub-id><?supplied-pmid 15767575?><pub-id pub-id-type="pmid">15767575</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Bezemer, D. <italic>et al</italic>. Dispersion of the HIV-1 Epidemic in Men Who Have Sex with Men in the Netherlands: A Combined Mathematical Model and Phylogenetic Analysis. <italic>PLoS Med</italic>. <bold>12</bold>, e1001898; discussion e1001898 (2015).</mixed-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magiorkinis</surname><given-names>G</given-names></name><etal/></person-group><article-title>The global spread of HIV-1 subtype B epidemic</article-title><source>Infect. Genet. Evol.</source><year>2016</year><volume>46</volume><fpage>169</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2016.05.041</pub-id><?supplied-pmid 27262355?><pub-id pub-id-type="pmid">27262355</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beloukas</surname><given-names>A</given-names></name><etal/></person-group><article-title>Molecular epidemiology of HIV-1 infection in Europe: An overview</article-title><source>Infect. Genet. Evol.</source><year>2016</year><volume>46</volume><fpage>180</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2016.06.033</pub-id><?supplied-pmid 27321440?><pub-id pub-id-type="pmid">27321440</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousseeuw</surname><given-names>PJ</given-names></name><name><surname>Ruts</surname><given-names>I</given-names></name><name><surname>Tukey</surname><given-names>JW</given-names></name></person-group><article-title>The Bagplot: A Bivariate Boxplot</article-title><source>Am. Stat.</source><year>1999</year><volume>53</volume><fpage>382</fpage><lpage>387</lpage></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yebra</surname><given-names>G</given-names></name><etal/></person-group><article-title>Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-na&#x000ef;ve HIV-infected patients (CoRIS) are due to recombinant viruses</article-title><source>J. Clin. Microbiol.</source><year>2012</year><volume>50</volume><fpage>407</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1128/JCM.05798-11</pub-id><?supplied-pmid 22162552?><pub-id pub-id-type="pmid">22162552</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yebra</surname><given-names>G</given-names></name><name><surname>Holgu&#x000ed;n</surname><given-names>A</given-names></name><name><surname>Pillay</surname><given-names>D</given-names></name><name><surname>Hu&#x000e9;</surname><given-names>S</given-names></name></person-group><article-title>Phylogenetic and demographic characterization of HIV-1 transmission in Madrid, Spain</article-title><source>Infect. Genet. Evol.</source><year>2013</year><volume>14</volume><fpage>232</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2012.12.006</pub-id><?supplied-pmid 23291408?><pub-id pub-id-type="pmid">23291408</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pati&#x000f1;o-Galindo</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Transmission dynamics of HIV-1 subtype B in the Basque Country, Spain</article-title><source>Infect. Genet. Evol.</source><year>2016</year><volume>40</volume><fpage>91</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2016.02.028</pub-id><?supplied-pmid 26921800?><pub-id pub-id-type="pmid">26921800</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pati&#x000f1;o-Galindo</surname><given-names>J&#x000c1;</given-names></name><etal/></person-group><article-title>Identification of a large, fast-expanding HIV-1 subtype B transmission cluster among MSM in Valencia, Spain</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><fpage>e0171062</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0171062</pub-id><?supplied-pmid 28152089?><pub-id pub-id-type="pmid">28152089</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemelaar</surname><given-names>J</given-names></name></person-group><article-title>The origin and diversity of the HIV-1 pandemic</article-title><source>Trends Mol. Med.</source><year>2012</year><volume>18</volume><fpage>182</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2011.12.001</pub-id><?supplied-pmid 22240486?><pub-id pub-id-type="pmid">22240486</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buonaguro</surname><given-names>L</given-names></name><name><surname>Tornesello</surname><given-names>ML</given-names></name><name><surname>Buonaguro</surname><given-names>FM</given-names></name></person-group><article-title>Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications</article-title><source>J. Virol.</source><year>2007</year><volume>81</volume><fpage>10209</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1128/JVI.00872-07</pub-id><?supplied-pmid 17634242?><pub-id pub-id-type="pmid">17634242</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bello</surname><given-names>G</given-names></name><name><surname>Afonso</surname><given-names>JM</given-names></name><name><surname>Morgado</surname><given-names>MG</given-names></name></person-group><article-title>Phylodynamics of HIV-1 subtype F1 in Angola, Brazil and Romania</article-title><source>Infect. Genet. Evol.</source><year>2012</year><volume>12</volume><fpage>1079</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.meegid.2012.03.014</pub-id><?supplied-pmid 22484759?><pub-id pub-id-type="pmid">22484759</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez-Alba</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>10755</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1128/JVI.00454-11</pub-id><?supplied-pmid 21795343?><pub-id pub-id-type="pmid">21795343</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Wyl</surname><given-names>V</given-names></name><etal/></person-group><article-title>The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland</article-title><source>J. Infect. Dis.</source><year>2011</year><volume>204</volume><fpage>1095</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir491</pub-id><pub-id pub-id-type="pmid">21881125</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dauwe</surname><given-names>K</given-names></name><etal/></person-group><article-title>Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate</article-title><source>BMC Infect. Dis.</source><year>2015</year><volume>15</volume><fpage>524</fpage><pub-id pub-id-type="doi">10.1186/s12879-015-1217-0</pub-id><?supplied-pmid 26572861?><pub-id pub-id-type="pmid">26572861</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>A</given-names></name><etal/></person-group><article-title>Analysis of a local HIV-1 epidemic in portugal highlights established transmission of non-B and non-G subtypes</article-title><source>J. Clin. Microbiol.</source><year>2015</year><volume>53</volume><fpage>1506</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1128/JCM.03611-14</pub-id><?supplied-pmid 25694526?><pub-id pub-id-type="pmid">25694526</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e1;rtolo</surname><given-names>I</given-names></name><etal/></person-group><article-title>Origin and Epidemiological History of HIV-1 CRF14_BG</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e24130</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0024130</pub-id><?supplied-pmid 21969855?><pub-id pub-id-type="pmid">21969855</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-&#x000c1;lvarez</surname><given-names>L</given-names></name><etal/></person-group><article-title>Predominance of CXCR4 tropism in HIV-1 CRF14_BG strains from newly diagnosed infections</article-title><source>J. Antimicrob. Chemother.</source><year>2014</year><volume>69</volume><fpage>246</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1093/jac/dkt305</pub-id><?supplied-pmid 23900735?><pub-id pub-id-type="pmid">23900735</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niculescu</surname><given-names>I</given-names></name><etal/></person-group><article-title>Recent HIV-1 Outbreak Among Intravenous Drug Users in Romania: Evidence for Cocirculation of CRF14_BG and Subtype F1 Strains</article-title><source>AIDS Res. Hum. Retroviruses</source><year>2015</year><volume>31</volume><fpage>488</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1089/aid.2014.0189</pub-id><?supplied-pmid 25369079?><pub-id pub-id-type="pmid">25369079</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paraskevis</surname><given-names>D</given-names></name><etal/></person-group><article-title>Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e78941</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0078941</pub-id><?supplied-pmid 24265730?><pub-id pub-id-type="pmid">24265730</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pati&#x000f1;o Galindo</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Expansion of the CRF19_cpx Variant in Spain</article-title><source>J. Clin. Virol.</source><year>2015</year><volume>69</volume><fpage>146</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2015.06.094</pub-id><?supplied-pmid 26209397?><pub-id pub-id-type="pmid">26209397</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yebra</surname><given-names>G</given-names></name><etal/></person-group><article-title>Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade</article-title><source>Arch. Virol.</source><year>2014</year><volume>159</volume><fpage>1079</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1007/s00705-013-1933-y</pub-id><?supplied-pmid 24297490?><pub-id pub-id-type="pmid">24297490</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>SYW</given-names></name><name><surname>Shapiro</surname><given-names>B</given-names></name></person-group><article-title>Skyline-plot methods for estimating demographic history from nucleotide sequences</article-title><source>Mol. Ecol. Resour.</source><year>2011</year><volume>11</volume><fpage>423</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1111/j.1755-0998.2011.02988.x</pub-id><?supplied-pmid 21481200?><pub-id pub-id-type="pmid">21481200</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aiewsakun</surname><given-names>P</given-names></name><name><surname>Katzourakis</surname><given-names>A</given-names></name></person-group><article-title>Time dependency of foamy virus evolutionary rate estimates</article-title><source>BMC Evol. Biol.</source><year>2015</year><volume>15</volume><fpage>119</fpage><pub-id pub-id-type="doi">10.1186/s12862-015-0408-z</pub-id><?supplied-pmid 26111824?><pub-id pub-id-type="pmid">26111824</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aiewsakun</surname><given-names>P</given-names></name><name><surname>Katzourakis</surname><given-names>A</given-names></name></person-group><article-title>Time-Dependent Rate Phenomenon in Viruses</article-title><source>J. Virol.</source><year>2016</year><volume>90</volume><fpage>7184</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1128/JVI.00593-16</pub-id><?supplied-pmid 27252529?><pub-id pub-id-type="pmid">27252529</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu&#x000e9;</surname><given-names>S</given-names></name><name><surname>Clewley</surname><given-names>JP</given-names></name><name><surname>Cane</surname><given-names>PA</given-names></name><name><surname>Pillay</surname><given-names>D</given-names></name></person-group><article-title>HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy</article-title><source>AIDS</source><year>2004</year><volume>18</volume><fpage>719</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1097/00002030-200403260-00002</pub-id><?supplied-pmid 15075506?><pub-id pub-id-type="pmid">15075506</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>AS</given-names></name><name><surname>Pybus</surname><given-names>OG</given-names></name><name><surname>Sanders</surname><given-names>EJ</given-names></name><name><surname>Albert</surname><given-names>J</given-names></name><name><surname>Esbj&#x000f6;rnsson</surname><given-names>J</given-names></name></person-group><article-title>Defining HIV-1 transmission clusters based on sequence data</article-title><source>AIDS</source><year>2017</year><volume>31</volume><fpage>1211</fpage><lpage>1222</lpage><pub-id pub-id-type="doi">10.1097/QAD.0000000000001470</pub-id><?supplied-pmid 28353537?><pub-id pub-id-type="pmid">28353537</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabowski</surname><given-names>MK</given-names></name><name><surname>Redd</surname><given-names>AD</given-names></name></person-group><article-title>Molecular tools for studying HIV transmission in sexual networks</article-title><source>Curr. Opin. HIV AIDS</source><year>2014</year><volume>9</volume><fpage>126</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000040</pub-id><?supplied-pmid 24384502?><pub-id pub-id-type="pmid">24384502</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guindon</surname><given-names>S</given-names></name><etal/></person-group><article-title>New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0</article-title><source>Syst. Biol.</source><year>2010</year><volume>59</volume><fpage>307</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/sysbio/syq010</pub-id><?supplied-pmid 20525638?><pub-id pub-id-type="pmid">20525638</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunar</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Bridging epidemiology with population genetics in a low incidence MSM-driven HIV-1 subtype B epidemic in Central Europe</article-title><source>BMC Infect. Dis.</source><year>2015</year><volume>15</volume><fpage>65</fpage><pub-id pub-id-type="doi">10.1186/s12879-015-0802-6</pub-id><?supplied-pmid 25887543?><pub-id pub-id-type="pmid">25887543</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drummond</surname><given-names>AJ</given-names></name><name><surname>Rambaut</surname><given-names>A</given-names></name></person-group><article-title>BEAST: Bayesian evolutionary analysis by sampling trees</article-title><source>BMC Evol. Biol.</source><year>2007</year><volume>7</volume><fpage>214</fpage><pub-id pub-id-type="doi">10.1186/1471-2148-7-214</pub-id><?supplied-pmid 17996036?><pub-id pub-id-type="pmid">17996036</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="other">R Core Team. <italic>R: A language and environment for statistical computing</italic>. (R Foundation for Statistical computing, 2014).</mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Croissant, Y. <italic>Package mlogit</italic>. (2015).</mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Paradis, E. <italic>et al</italic>. Package &#x02018;ape&#x02019; (2017).</mixed-citation></ref></ref-list></back></article>